-
1
Supplementary Figure S1 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model
منشور في 2025مؤلفون آخرون: "…Jacqueline C. Barrientos (15314299)…"
-
2
Supplementary Figure S2 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model
منشور في 2025مؤلفون آخرون: "…Jacqueline C. Barrientos (15314299)…"
-
3
Supplementary Figure S3 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model
منشور في 2025مؤلفون آخرون: "…Jacqueline C. Barrientos (15314299)…"
-
4
Supplementary Figure S6 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model
منشور في 2025مؤلفون آخرون: "…Jacqueline C. Barrientos (15314299)…"
-
5
Supplementary Table S1 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model
منشور في 2025مؤلفون آخرون: "…Jacqueline C. Barrientos (15314299)…"
-
6
Supplementary Figure S4 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model
منشور في 2025مؤلفون آخرون: "…Jacqueline C. Barrientos (15314299)…"
-
7
Supplementary Figure S5 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model
منشور في 2025مؤلفون آخرون: "…Jacqueline C. Barrientos (15314299)…"